Search Form
First, enter a politician or zip code
Now, choose a category
 

Greg Walden's Public Statements on Issue: Health and Health Care

Office: U.S. House (OR) - District 2, Republican
Date Title
June 29, 2017 McMorris Rodgers, Herrera Beutler, Newhouse, Schrader, and Walden Introduce Legislation to Address FCRPS Biological Opinion
June 20, 2017 Walden and Murphy Comment on Overdue Release of HHS' Pandemic Influenza Plan
June 15, 2017 Hearing of the Environment Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Markup on the Nuclear Waste Policy Amendments Act of 2017 and the Brownfields Enhancement Economic Redevelopment and Reauthorization Act of 2017
June 12, 2017 Walden and Burgess Comment on 2017 Obamacare Enrollment
June 8, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Examining the Role of the Department of Health and Human Services in Health Care Cybersecurity
June 7, 2017 #FullCmte Advances #FDARA, Public Health Bills, and 11 #EnergyInfrastructure Bills
June 1, 2017 Letter to George Sigounas, Administrator of Health Resources and Services Administration, U.S. Dept. of Health and Human Services - Audit Request Regarding 340B Program
June 1, 2017 Chairman Walden on Administration's Paris Decision
May 24, 2017 Letter to the Hon. Gene Dodaro, Comptroller General of the U.S. Government Accountability Office - Calling on GAO to Review Unfinished Work at Hanford Nuclear Reservation
May 24, 2017 Walden and Burgess on CBO Score of American Health Care Act
May 23, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on U.S. Public Health Response to the Zika Virus: Continuing Challenges
May 18, 2017 Walden & Pallone Announce Bipartisan Task Force to Examine Indian Health Service
May 17, 2017 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Examining Initiatives to Advance Public Health
May 9, 2017 Walden and Burgess Comment on Scott Gottlieb's Confirmation as FDA Commissioner
May 8, 2017 Letter to AmerisourceBergen Corporation, CardinalHealth, McKesson Corporation and the Drug Enforcement Administration - Alleged Pill Dumping in West Virginia
May 4, 2017 Walden and Burgess on House Passage of American Health Care Act
May 3, 2017 Walden Statement on AHCA
May 2, 2017 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Examining Improvements to the Regulation of Medical Technologies
May 1, 2017 The Washington Times - Energy goals: Jobs, production, modern infrastructure -- and good environmental stewardship
April 28, 2017 Oregon Representatives Introduce Bipartisan Legislation To Protect Communities, Establish Emergency Response Fund For Rail Accidents
April 20, 2017 Letter to the Hon. Thomas E. Price, Secretary of Health and Human Services - Status of Pandemic Influenza Plan
April 19, 2017 HHS to Issue First Round of Opioid Grants from 21st Century Cures Act
April 4, 2017 Hearing of the Environment Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Brownfields Reauthorization: Discussion Draft
April 4, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Cybersecurity in the Health Care Sector: Strengthening Public-Private Partnerships
March 29, 2017 E&C Leaders Comment on President Trump's Executive Action to Address Opioid Epidemic
March 28, 2017 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Greg Walden, Hearing on Examining FDA's Medical Device User Fee Program
March 28, 2017 Committee Leaders Comment on Administration's Energy Executive Order
March 28, 2017 #SubHealth Looks at Reauthorization of Medical Device User Fee Program
March 22, 2017 Hearing of the Environment Subcommitee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on H.R. 806, Ozone Standards Implementation Act of 2017
March 21, 2017 Hearing of the Oversight and Investigations Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Fentanyl: The Next Wave of the Opioid Crisis
March 20, 2017 House Republicans Announce Updates to Strengthen American Health Care Act
March 16, 2017 Hearing of the Environment Subcommitee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Reinvestment and Rehabilitation of Our Nation's Safe Drinking Water Delivery Systems
March 15, 2017 Letter to Dr. Stephen Ostroff, Acting Commissioner of the Food and Drug Administration - Provide Documents Related to Heparin Contamination Crisis
March 13, 2017 Walden and Burgess Comment on Seema Verma's Confirmation as CMS Administrator
March 13, 2017 Walden Statement on CBO Score of American Health Care Act
March 9, 2017 Energy and Commerce Committee Advances Legislation to Repeal and Replace Obamacare
March 9, 2017 Energy and Commerce Committee Advances Legislation to Repeal and Replace Obamacare
March 7, 2017 The Wall Street Journal - The Health Bill You've Waited For
March 7, 2017 The Wall Street Journal - The Health Bill You've Waited For
March 6, 2017 Energy and Commerce Republicans Release Legislation to Repeal and Replace Obamacare
March 6, 2017 E&C Releases Compendium on Obamacare Oversight
March 2, 2017 Walden Statement on Repealing and Replacing Obamacare
March 2, 2017 Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Opening Statement of Rep. Walden, Hearing on Examining FDA's Generic Drug and Biosimilar User Fee Programs
Feb. 28, 2017 #SubOversight Examines International Anti-Doping System With All-Star Panel
Feb. 28, 2017 Walden Statement on President Trump's Health Care Reform Plan
Feb. 28, 2017 Letter to Dr. Schuchat, Acting Director for the Centers for Disease Control nad Prevention - Provide
Feb. 23, 2017 Letter to Mr. Kemp Chester, Acting Director of the the Office of National Dug Control Policy - Provide Assistance in Questioning all Federal Agencies on Plans to Address Fentanyl
Feb. 21, 2017 Letter to Congressional Colleagues - Vaccines Save Lives
Feb. 21, 2017 Letter to Congress - Vaccines Save Lives
Feb. 21, 2017 Letter to Ms. Catherine McCab, Acting Administrator of the U.S. Environmental Protection Agency; Mr. Kevin Minoli, Acting General Counsel of the U.S. Environmental Protection Agency; and Mr. Donald Benton, White House Liaison to the U.S. Environmental Protection Agency - Please Grant 120-Day Extension to EPA's PRoposed Rule
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top